By Nabihah Sachedina, MBBS, MPP, MBA
LEARNING OBJECTIVES
Upon completion of this article, the reader will be able to:
- List past testing paradigms in the diagnosis of rare pediatric diseases.
- Describe the factors and benefits for the advancement of molecular diagnostics in rare pediatric diseases.
- Describe the type of mutations that different molecular sequencing tests can identify.
- Discuss the prevalence and disease rates and cause of rare pediatric diseases.
Nabihah Sachedina, MBBS, MPP, MBA currently serves as Vice President, Health Programs, at Oxford Nanopore Technologies. She is a UK-trained pediatrician who has spent more than a decade developing and implementing city-wide, regional, and national public health and healthcare policy.
Cover photo credit: Photo 56463226 © Aviahuismanphotography | Dreamstime.com
Login
Accessing this course requires a login. Please enter your credentials below!